Case report: Novel leg vein treatment CLaCS guided by augmented reality 11 years follow‐up

Abstract

AbstractTelangiectasias is most prevalent on the lower limbs and has been estimated to manifest in 40%–90% of the population. Treatments for telangiectasias include sclerotherapy, laser therapy, intense pulsed light treatment, microphlebectomy, and thermocoagulation. Cryo‐Laser & Cryo‐Sclerotherapy (CLaCS) effectively combines thermal and injection sclerotherapy. In this treatment, unwanted veins are targeted by a transdermal laser and immediately receive injection sclerotherapy. During the whole procedure, an air‐cooling device (Cryo) blows onto the surrounding skin and tissue to prevent skin burn. Here, we present a case report of a challenging telangiectasias treated with ClaCS.